| Discovery of potent myeloid cell leukemia-1 (Mcl-1) inhibitors that demonstrate in vivo activity in mouse xenograft models of human cancer T Lee, PP Christov, S Shaw, JC Tarr, B Zhao, N Veerasamy, KO Jeon, ... Journal of medicinal chemistry 62 (8), 3971-3988, 2019 | 47 | 2019 |
| Fragment-based screening of programmed death ligand 1 (PD-L1) E Perry, JJ Mills, B Zhao, F Wang, Q Sun, PP Christov, JC Tarr, TA Rietz, ... Bioorganic & medicinal chemistry letters 29 (6), 786-790, 2019 | 45 | 2019 |
| Discovery and structure-based optimization of potent and selective WD repeat domain 5 (WDR5) inhibitors containing a dihydroisoquinolinone bicyclic core J Tian, KB Teuscher, ER Aho, JR Alvarado, JJ Mills, KM Meyers, ... Journal of medicinal chemistry 63 (2), 656-675, 2019 | 40 | 2019 |
| Synthesis and biological evaluation of the antimicrobial natural product lipoxazolidinone A JJ Mills, KR Robinson, TE Zehnder, JG Pierce Angewandte Chemie 130 (28), 8818-8822, 2018 | 29 | 2018 |
| Discovery of potent orally bioavailable WD repeat domain 5 (WDR5) inhibitors using a pharmacophore-based optimization KB Teuscher, KM Meyers, Q Wei, JJ Mills, J Tian, J Alvarado, J Sai, ... Journal of medicinal chemistry 65 (8), 6287-6312, 2022 | 16 | 2022 |
| Fragment-based discovery of small molecules bound to T-cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) TA Rietz, KB Teuscher, JJ Mills, RD Gogliotti, LT Lepovitz, WR Scaggs, ... Journal of medicinal chemistry 64 (19), 14757-14772, 2021 | 15 | 2021 |
| Enantiospecific Synthesis of β-Substituted Tryptamines HN Rubin, K Van Hecke, JJ Mills, J Cockrell, JB Morgan Organic letters 19 (18), 4976-4979, 2017 | 13 | 2017 |
| Synthesis of the cyanobacterial antibiotics anaephenes A and B DL Kukla, J Canchola, JJ Mills Journal of natural products 83 (6), 2036-2040, 2020 | 10 | 2020 |
| Expanded structure–activity studies of lipoxazolidinone antibiotics KR Robinson, JJ Mills, JG Pierce ACS Medicinal Chemistry Letters 10 (3), 374-377, 2019 | 9 | 2019 |
| Design, synthesis, and evaluation of substrate–analogue inhibitors of Trypanosoma cruzi ribose 5-phosphate isomerase type B SN Gonzalez, JJ Mills, D Maugeri, C Olaya, BL Laguera, JR Enders, ... Bioorganic & Medicinal Chemistry Letters 32, 127723, 2021 | 5 | 2021 |
| A Ru (ii)-arene-ferrocene complex with promising antibacterial activity S Mensah, JD Rosenthal, M Dagar, T Brown, JJ Mills, CG Hamaker, ... Dalton Transactions 51 (46), 17609-17619, 2022 | 3 | 2022 |
| Design, synthesis, and structure–activity relationship studies of the anaephene antibiotics DL Kukla, J Canchola, JD Rosenthal, JJ Mills Chemical Biology & Drug Design 98 (2), 295-304, 2021 | 3 | 2021 |
| 4-oxazolidinone antimicrobial agents JG Pierce, JJ Mills US Patent 10,844,025, 2020 | 1 | 2020 |
| Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors KB Teuscher, JJ Mills, J Tian, C Han, KM Meyers, J Sai, TM South, ... Journal of Medicinal Chemistry 66 (24), 16783-16806, 2023 | | 2023 |
| 4-oxazolidinone antimicrobial agents JG Pierce, JJ Mills US Patent 11,673,869, 2023 | | 2023 |
| Wdr5 inhibitors and modulators T Lee, JR Alvarado, T Jianhua, KM Meyers, HAN Changho, JJ Mills, ... US Patent App. 17/287,492, 2023 | | 2023 |
| Wdr5 inhibitors and modulators T Lee, HAN Changho, JJ Mills, KB Teuscher, T Jianhua, KM Meyers, ... US Patent App. 17/613,717, 2022 | | 2022 |
| WDR5-MLL1 inhibitors and modulators RD Gogliotti, SR Stauffer, KO Jeon, JM Salovich, JD Macdonald, JJ Mills, ... US Patent 10,807,959, 2020 | | 2020 |
| Synthesis and Biological Evaluation of Aspidosperma Alkaloids and 4-Oxazolidinone Natural Products J Mills North Carolina State University, 2017 | | 2017 |
| Synthesis of enantioenriched beta-substituted tryptamine derivatives K Van Hecke, H Rubin, J Mills, J Cockrell, J Morgan ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016 | | 2016 |
